Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 826 AL 840

Spiritual Fitness: A New Dimension in Alzheimer's Disease Prevention

Khalsa DS, Newberg AB.

J Alzheimers Dis. 2021;80(2):505-519. doi: 10.3233/JAD-201433.

Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease

Thapa P, Upadhyay SP, Suo WZ, Singh V, Gurung P, Lee ES, Sharma R, Sharma M.

Bioorg Chem. 2021 Mar;108:104681. doi: 10.1016/j.bioorg.2021.104681. Epub 2021 Jan 29.

The application of multifunctional nanomaterials in Alzheimer's disease: A potential theranostics strategy

Xu Y, Zhao M, Zhou D, Zheng T, Zhang H.

Biomed Pharmacother. 2021 May;137:111360. doi: 10.1016/j.biopha.2021.111360. Epub 2021 Feb 11.

Machine Learning Algorithms and Statistical Approaches for Alzheimer's Disease Analysis Based on Resting-State EEG Recordings: A Systematic Review

Tzimourta KD, Christou V, Tzallas AT, Giannakeas N, Astrakas LG, Angelidis P, Tsalikakis D, Tsipouras MG.

Int J Neural Syst. 2021 May;31(5):2130002. doi: 10.1142/S0129065721300023. Epub 2021 Feb 16.

What is 'Alzheimer's disease'? The neuropathological heterogeneity of clinically defined Alzheimer's dementia

Mehta RI, Schneider JA.

Curr Opin Neurol. 2021 Apr 1;34(2):237-245. doi: 10.1097/WCO.0000000000000912.

A systematic review of atypical Alzheimer's disease including behavioural and psychological symptoms

Shea YF, Pan Y, Mak HK, Bao Y, Lee SC, Chiu PK, Chan HF.

Psychogeriatrics. 2021 May;21(3):396-406. doi: 10.1111/psyg.12665. Epub 2021 Feb 16.

A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease

Yang A, Liu C, Wu J, Kou X, Shen R.

Eur J Pharmacol. 2021 Apr 15;897:173950. doi: 10.1016/j.ejphar.2021.173950. Epub 2021 Feb 16.

Associations of Omega-3 fatty acids with brain morphology and volume in cognitively healthy older adults: A narrative review

Macaron T, Giudici KV, Bowman GL, Sinclair A, Stephan E, Vellas B, de Souto Barreto P.

Ageing Res Rev. 2021 May;67:101300. doi: 10.1016/j.arr.2021.101300. Epub 2021 Feb 16.

KL∗VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗4 carriers

Belloy ME, Eger SJ, Le Guen Y, Napolioni V, Deters KD, Yang HS, Scelsi MA, Porter T, James SN, Wong A, Schott JM, Sperling RA, Laws SM, Mormino EC, He Z, Han SS, Altmann A, Greicius MD; A4 Study Team; Insight 46 Study Team; Australian Imaging Biomarkers and Lifestyle (AIBL) Study; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2021 May;101:123-129. doi: 10.1016/j.neurobiolaging.2021.01.008. Epub 2021 Jan 23.

Role of natural products for the treatment of Alzheimer's disease

Noori T, Dehpour AR, Sureda A, Sobarzo-Sanchez E, Shirooie S.

Eur J Pharmacol. 2021 May 5;898:173974. doi: 10.1016/j.ejphar.2021.173974. Epub 2021 Feb 27.

Early Detection of Incipient Alzheimer Pathology: Time Is of the Essence

Barkhof F, Pressman PS.

Neurology. 2021 Apr 6;96(14):647-648. doi: 10.1212/WNL.0000000000011739. Epub 2021 Mar 2.

Amyloid burden quantification depends on PET and MR image processing methodology

Kolinger GD, Vállez García D, Willemsen ATM, Reesink FE, de Jong BM, Dierckx RAJO, De Deyn PP, Boellaard R.

PLoS One. 2021 Mar 5;16(3):e0248122. doi: 10.1371/journal.pone.0248122. eCollection 2021.

Alzheimer's disease

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM.

Lancet. 2021 Apr 24;397(10284):1577-1590. doi: 10.1016/S0140-6736(20)32205-4. Epub 2021 Mar 2.

Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies

Shabbir U, Arshad MS, Sameen A, Oh DH.

Nutrients. 2021 Feb 21;13(2):690. doi: 10.3390/nu13020690.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias